tirzepatide fda indications Big update in pediatric diabetes care 🩺 Mounjaro® (tirzepatide) is now FDA- approved for children ≥10 years old with Type 2 diabetes as an adjunct to diet and exercise. What this means ⬇️ What are the FDA indications

In rare cases, severe dehydration can cause acute kidney injury, especially in older adults or those with preexisting kidney disease

This tachyphylaxis of gastric emptying is best documented for long-acting GLP-1 receptor agonists, where short-acting agents produce large, sustained emptying delays while long-acting agents produce an emptying delay that wanes with continued dosing

People may seek out IV glutathione for its potential to brighten their complexion and to whiten skin

Gi cho ln da mm mi, mn mng v trn y sc sng

If you're taking insulin, sulfonylureas, or other diabetes medications alongside GLP-1 therapy, you're at higher risk for hypoglycemia

Tirzepatide targets a second hormone, called glucose-dependent insulinotropic polypeptide, or GIP